Does TINZAPARIN Cause Incorrect product administration duration? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Incorrect product administration duration have been filed in association with TINZAPARIN. This represents 0.6% of all adverse event reports for TINZAPARIN.
11
Reports of Incorrect product administration duration with TINZAPARIN
0.6%
of all TINZAPARIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Incorrect product administration duration From TINZAPARIN?
Of the 11 reports, and 11 (100.0%) were considered life-threatening.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TINZAPARIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TINZAPARIN Cause?
Acute kidney injury (135)
Anaemia (118)
Off label use (110)
Maternal exposure during pregnancy (108)
Thrombocytopenia (86)
Drug ineffective (82)
Toxic epidermal necrolysis (80)
Hepatocellular injury (70)
Premature baby (70)
Cholestasis (67)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which TINZAPARIN Alternatives Have Lower Incorrect product administration duration Risk?
TINZAPARIN vs TIOCONAZOLE
TINZAPARIN vs TIOPRONIN
TINZAPARIN vs TIOTROPIUM
TINZAPARIN vs TIPIRACIL\TRIFLURIDINE
TINZAPARIN vs TIPRANAVIR